Ritual vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Traceable DTC vitamin brand with $250M+ gross revenue in 2024; launched at Walmart in 2025; advocates for supplement industry regulation; discloses every ingredient supplier in minimalist formulas across multivitamins, prenatal, and protein products.
About
Ritual is a Los Angeles-based women's health supplement company founded in 2015 by Katerina Markov Schneider. The company is known for its minimalist, transparent multivitamin formulas that disclose every ingredient supplier and reason for inclusion. Ritual has raised approximately $68 million in total, with a Series B led by Norwest Venture Partners.\n\nRitual reported more than $250 million in gross revenue in 2024, fueled by its flagship Essential for Women multivitamins and an expanding product line covering prenatal vitamins, protein powders, and children's supplements. In 2025, Ritual launched a line of multivitamin formulas at Walmart, marking a major pivot toward mass retail alongside its longstanding DTC subscription model.\n\nFounder Katerina Schneider has become a vocal advocate for supplement industry reform, testifying before Congress in early 2025 to push for stronger FDA oversight of nutritional supplements. This advocacy reinforces the brand's transparency positioning and distinguishes Ritual in a category where quality control is often opaque. The brand appeals to millennial and Gen Z consumers who prioritize ingredient traceability and science-backed formulation.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.